Nuzenio

Ono Pharma

Ono Pharma news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 15 latest news signals 11 publisher sources 100/100 entity strength

Latest news

Japan's Ono Pharmaceutical Funds Fibrosis Discovery After Lilly's $99M Bet on Same Biotech - Tech TimesTech Times · Fri, 07 Aug 2026 17:47:39 GMT Mediar Therapeutics enters option deal with Ono Pharma - The Pharma LetterThe Pharma Letter · Fri, 07 Aug 2026 10:18:54 GMT Mediar and Ono Pharmaceutical to develop fibro-inflammatory treatments - Yahoo FinanceYahoo Finance · Fri, 07 Aug 2026 09:43:22 GMT Mediar and Ono to Develop Novel Treatments Targeting Fibro-Inflammatory Diseases - Contract PharmaContract Pharma · Thu, 06 Aug 2026 20:17:24 GMT Mediar partners with Ono Pharma on fibro-inflammatory discovery - AllSciAllSci · Thu, 06 Aug 2026 16:25:44 GMT Ono Pharma Enters into a Drug Discovery Partnership with Mediar Therapeutics to Create Novel Antibody Therapeutics for Fibro-inflammatory Diseases - BioSpaceBioSpace · Thu, 06 Aug 2026 12:41:31 GMT Mediar Therapeutics Enters into a Collaboration and Option Agreement with Ono Pharma to Develop Novel Treatments for Fibro-inflammatory Diseases - PR NewswirePR Newswire · Thu, 06 Aug 2026 11:00:00 GMT Mediar Therapeutics Enters Antibody Collaboration with Ono Pharma for Fibro-Inflammatory Diseases - BioPharm InternationalBioPharm International · Thu, 06 Aug 2026 07:00:00 GMT

Timeline

Fri, 07 Aug 2026 17:47:39 GMTJapan's Ono Pharmaceutical Funds Fibrosis Discovery After Lilly's $99M Bet on Same Biotech - Tech Times

Fri, 07 Aug 2026 10:18:54 GMTMediar Therapeutics enters option deal with Ono Pharma - The Pharma Letter

Fri, 07 Aug 2026 09:43:22 GMTMediar and Ono Pharmaceutical to develop fibro-inflammatory treatments - Yahoo Finance

Thu, 06 Aug 2026 20:17:24 GMTMediar and Ono to Develop Novel Treatments Targeting Fibro-Inflammatory Diseases - Contract Pharma

Thu, 06 Aug 2026 16:25:44 GMTMediar partners with Ono Pharma on fibro-inflammatory discovery - AllSci

Thu, 06 Aug 2026 12:41:31 GMTOno Pharma Enters into a Drug Discovery Partnership with Mediar Therapeutics to Create Novel Antibody Therapeutics for Fibro-inflammatory Diseases - BioSpace

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.

Connected entities

Results8 live mentions Fibro6 live mentions Earnings Report6 live mentions Call6 live mentions Ltd5 live mentions Mediar Therapeutics4 live mentions Develop Novel Treatments4 live mentions Phylo4 live mentions Mediar3 live mentions Ono Pharmaceutical3 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Ono Pharma.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

11 distinct publisher/source names are currently connected to this entity page.